Home » Topics » Regulatory » Patents

Patents
RSS

Excessive scarring prevented by 4-hydroxy tamoxifen (4-OHT)

Feb. 18, 2005

New serotonin 5-HT1B receptor antagonists identified at Pfizer

Feb. 17, 2005

Six series of phosphatidylinositol 3-kinase inhibitors and their use reported by Pfizer

Feb. 17, 2005

Novel PPAR ligands jointly disclosed by Fujisawa and Daicel

Feb. 17, 2005

Pfizer claims new cannabinoid CB1 receptor antagonists for obesity

Feb. 17, 2005

Merck Frosst claims novel inhibitors of leukotriene biosynthesis

Feb. 16, 2005

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Feb. 16, 2005

New 5-HT receptor modulators claimed by Suven Life Sciences

Feb. 16, 2005

Genelabs Technologies presents novel antiviral agents

Feb. 16, 2005

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Feb. 16, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...